Study: NCT01827644

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Afuresertib HPMC capsule - Fasted State
Description: White opaque HPMC capsule containing afuresertib 25 mg. Subjects will receive single oral dose of afuresertib HPMC capsule administered in fasted state

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Afuresertib ECT - Fasted State
Description: White to off white, round, biconvex coated tablet containing afuresertib 25 mg. Subjects will receive single oral dose of afuresertib ECT administered in fasted state

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Afuresertib ECT - Fasted State
Description: White to off white, round, biconvex coated tablet containing afuresertib 25 mg. Subjects will receive single oral dose of afuresertib ECT administered in fasted state

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Afuresertib ECT - Fasted State
Description: White to off white, round, biconvex coated tablet containing afuresertib 25 mg. Subjects will receive single oral dose of afuresertib ECT administered in fasted state

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Afuresertib ECT - Fasted State
Description: White to off white, round, biconvex coated tablet containing afuresertib 25 mg. Subjects will receive single oral dose of afuresertib ECT administered in fasted state

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Afuresertib GC - Fed State
Description: White opaque hard gelatin capsule containing afuresertib 25 mg. Subjects will receive single oral dose of afuresertib GC administered in fed state

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Afuresertib GC - Fed State
Description: White opaque hard gelatin capsule containing afuresertib 25 mg. Subjects will receive single oral dose of afuresertib GC administered in fed state

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Afuresertib GC - Fed State
Description: White opaque hard gelatin capsule containing afuresertib 25 mg. Subjects will receive single oral dose of afuresertib GC administered in fed state

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Afuresertib GC - Fed State
Description: White opaque hard gelatin capsule containing afuresertib 25 mg. Subjects will receive single oral dose of afuresertib GC administered in fed state

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Afuresertib HPMC capsule - Fed State
Description: White opaque HPMC capsule containing afuresertib 25 mg. Subjects will receive single oral dose of afuresertib HPMC capsule administered in fed state

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Afuresertib HPMC capsule - Fed State
Description: White opaque HPMC capsule containing afuresertib 25 mg. Subjects will receive single oral dose of afuresertib HPMC capsule administered in fed state

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Afuresertib HPMC capsule - Fed State
Description: White opaque HPMC capsule containing afuresertib 25 mg. Subjects will receive single oral dose of afuresertib HPMC capsule administered in fed state

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Afuresertib HPMC capsule - Fed State
Description: White opaque HPMC capsule containing afuresertib 25 mg. Subjects will receive single oral dose of afuresertib HPMC capsule administered in fed state

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Afuresertib ECT - Fed State
Description: White to off white, round, biconvex coated tablet containing afuresertib 25 mg. Subjects will receive single oral dose of afuresertib ECT administered in fed state

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Afuresertib ECT - Fed State
Description: White to off white, round, biconvex coated tablet containing afuresertib 25 mg. Subjects will receive single oral dose of afuresertib ECT administered in fed state

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Afuresertib ECT - Fed State
Description: White to off white, round, biconvex coated tablet containing afuresertib 25 mg. Subjects will receive single oral dose of afuresertib ECT administered in fed state

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Afuresertib ECT - Fed State
Description: White to off white, round, biconvex coated tablet containing afuresertib 25 mg. Subjects will receive single oral dose of afuresertib ECT administered in fed state